Avalon Pharma CEO Shares the Company’s Global Vision in an Inspiring Conversation with Forbes
2026-02-02
Interview
Avalon Pharma was honored to take part in an inspiring conversation with Forbes, featuring our CEO and Managing Director, Mr. Mohamed Maher Al Ghannam, who shared the company’s journey and strategic vision toward achieving a lasting global impact.
During the discussion, Mr. Al Ghannam highlighted Avalon Pharma’s evolution as a Saudi pharmaceutical company driven by science, innovation, and trust, emphasizing the organization’s commitment to delivering high-quality healthcare solutions while expanding its presence in regional and international markets.
The conversation shed light on Avalon Pharma’s focus on research and development, advanced manufacturing capabilities, and strategic partnerships that support sustainable growth and reinforce the Kingdom’s ambition to become a global hub for pharmaceutical and healthcare innovation.
This feature reflects Avalon Pharma’s strong positioning as a trusted pharmaceutical partner and its ongoing efforts to contribute meaningfully to global healthcare advancement, in
alignment with Saudi Vision 2030.
To watch the full episode:
Stay informed about the future of healthcare
Visit our newsroom today to stay up to date.
